| Pharmaceutical active ingredients: |
| Methylprednisolone Sodium Succinate |
| Available forms, composition and doses of Urbason: |
| Injectable; Injection; Methylprednisolone Sodium Succinate 16 mgInjectable; Injection; Methylprednisolone Sodium Succinate 32 mgTablets; Oral; Methylprednisolone Sodium Succinate 16 mgTablets; Oral; Methylprednisolone Sodium Succinate 4 mgTablets; Oral; Methylprednisolone Sodium Succinate 40 mgTablets; Oral; Methylprednisolone Sodium Succinate 8 mg |
| Urbason medical category: |
| Human:AdrenalsAnti-inflammatory agentsCorticosteroid hormonesEye corticosteroidsOestrogens and progesterones and related synthetic drugsTopical corticosteroidsTreatment of dermatological diseasesWeak (group I) corticosteroids |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D07AA01 - MethylprednisoloneD10AA02 - MethylprednisoloneH02AB04 - Methylprednisolone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Sol-U-Pred | Methylprednisolone Sodium Succinate | United Biotech |
| Solupren | Methylprednisolone Sodium Succinate | Bergamo Laboratorio Quimico Farmaceutico |
| Succimed | Methylprednisolone Sodium Succinate | VHB Lifesciences |
| Supresol | Methylprednisolone Sodium Succinate | Biologici Italia Laboratories |
| Systpred | Methylprednisolone Sodium Succinate | Systacare Remedies |
| Urbason Forte | Methylprednisolone Sodium Succinate | Sanofi-Aventis |
| Urbasone | Methylprednisolone Sodium Succinate | Sanofi-Aventis |
| Promedrol | Methylprednisolone Suleptanate | Pfizer |
| Zempred | Methylprednisolone; Methylprednisolone Aceponate | Sun Pharmaceutical Industries |
| Methylprednisolone | Methylprednisolone; Methylprednisolone Acetate | Sandoz |